Weaver Consulting Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$476K Sell
518
-8
-2% -$8.11K 0.11% 153
2025
Q4
$565K Hold
526
0.14% 131
2025
Q3
$401K Buy
526
+28
+6% +$20.8K 0.1% 155
2025
Q2
$388K Buy
498
+3
+0.6% +$2.33K 0.11% 151
2025
Q1
$409K Buy
495
+3
+0.6% +$2.5K 0.12% 139
2024
Q4
$380K Sell
492
-143
-23% -$118K 0.12% 137
2024
Q3
$563K Buy
635
+44
+7% +$39.6K 0.18% 101
2024
Q2
$535K Sell
591
-20
-3% -$16K 0.19% 98
2024
Q1
$475K Buy
611
+5
+0.8% +$3.56K 0.18% 106
2023
Q4
$353K Buy
606
+10
+2% +$5.84K 0.14% 127
2023
Q3
$320K Sell
596
-130
-18% -$67K 0.14% 130
2023
Q2
$340K Buy
726
+53
+8% +$22.2K 0.15% 121
2023
Q1
$231K Buy
673
+4
+0.6% +$1.35K 0.11% 157
2022
Q4
$245K Hold
669
0.12% 148
2022
Q3
$216K Buy
669
+5
+0.8% +$1.58K 0.12% 152
2022
Q2
$215K Sell
664
-75
-10% -$22.5K 0.12% 153
2022
Q1
$212K Hold
739
0.1% 164
2021
Q4
$204K Buy
+739
New +$187K 0.1% 163
2020
Q4
Sell
-640
Closed -$95K 559
2020
Q3
$95K Hold
640
0.05% 195
2020
Q2
$105K Buy
640
+9
+1% +$1.38K 0.06% 183
2020
Q1
$88K Hold
631
0.06% 176
2019
Q4
$71K Hold
631
0.04% 199
2019
Q3
$69K Hold
631
0.04% 199
2019
Q2
$70K Hold
631
0.04% 189
2019
Q1
$72K Buy
+631
New +$76.7K 0.02% 399

Other funds holding LLY

Weaver Consulting Group's LLY Position: Q1 2026 in Review

Weaver Consulting Group reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $8.11K and leaving 518 shares worth $476K. The position accounts for 0.11% of the portfolio, ranked #153.

Weaver Consulting Group first reported a position in LLY in Q1 2019 and has held it in 25 quarters since. The position peaked at $565K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Weaver Consulting Group held 518 shares of Eli Lilly worth $476K as of Q1 2026.
  • Weaver Consulting Group sold 8 Eli Lilly shares in Q1 2026, an estimated $8.11K.
  • Eli Lilly made up 0.11% of Weaver Consulting Group's portfolio in Q1 2026, its #153 holding.
  • Weaver Consulting Group first reported a position in Eli Lilly in Q1 2019 and has held it in 25 quarters since.
  • Weaver Consulting Group's Eli Lilly position peaked at $565K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Weaver Consulting Group's 13F filing for Q1 2026, filed 15 May 2026.